Evidence map›Paper›PMID 31892361›Full record

ArticleClinical epigenetics2019

Transient receptor potential ankyrin 1 promoter methylation and peripheral pain sensitivity in Crohn's disease.

Sara Gombert, Mathias Rhein, Andreas Winterpacht, Tino Münster, Thomas Hillemacher, Andreas Leffler, Helge Frieling

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Epigenetic Landscapes of Pain: DNA Methylation Dynamics in Chronic Pain.International journal of molecular sciences · 2024
    Review
  8. Roles of TRP and PIEZO receptors in autoimmune diseases.Expert reviews in molecular medicine · 2024
    Review
  9. Article
  10. Review
  11. Cannabis Pharmacogenomics: A Path to Personalized Medicine.Current issues in molecular biology · 2023
    Review
  12. DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sara GombertLaboratory for Molecular Neuroscience, Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Feodor-Lynen-Str. 35, 30625, Hannover, Germany. Gombert.Sara@mh-hannover.de.ORCID http://orcid.org/0000-0002-8118-6024
Mathias RheinLaboratory for Molecular Neuroscience, Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Feodor-Lynen-Str. 35, 30625, Hannover, Germany.
Andreas WinterpachtInstitute of Human Genetics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Tino MünsterDepartment of Anesthesiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Thomas HillemacherLaboratory for Molecular Neuroscience, Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Feodor-Lynen-Str. 35, 30625, Hannover, Germany.
Andreas Leffler *Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Helge Frieling *Laboratory for Molecular Neuroscience, Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Feodor-Lynen-Str. 35, 30625, Hannover, Germany.
Medizinische Hochschule Hannover · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCrohn's disease is a chronic inflammatory disorder of the gastrointestinal tract associated with abdominal pain and diarrhea. Pain caused by Crohn's disease likely involves neurogenic inflammation which seems to involve the ion channel transient receptor potential ankyrin 1 (TRPA1). Since the promoter methylation of TRPA1 was shown to influence pain sensitivity, we asked if the expression of TRPA1 is dysregulated in patients suffering from Crohn's disease. The methylation rates of CpG dinucleotides in the TRPA1 promoter region were determined from DNA derived from whole blood samples of Crohn patients and healthy participants. Quantitative sensory testing was used to examine pain sensitivities.

resultsPressure pain thresholds were lower in Crohn patients as compared to healthy participants, and they were also lower in females than in males. They correlated inversely with the methylation rate at the CpG - 628 site of the TRPA1 promoter. This effect was more pronounced in female compared to male Crohn patients. Similar results were found for mechanical pain thresholds. Furthermore, age-dependent effects were detected. Whereas the CpG - 628 methylation rate declined with age in healthy participants, the methylation rate in Crohn patients increased. Pressure pain thresholds increased with age in both cohorts.

conclusionsThe TRPA1 promoter methylation appears to be dysregulated in patients suffering from Crohn's disease, and this effect is most obvious when taking gender and age into account. As TRPA1 is regarded to be involved in pain caused by neurogenic inflammation, its aberrant expression may contribute to typical symptoms of Crohn's disease.

Indexed as

DNA MethylationAdultCase-Control StudiesCpG IslandsCrohn DiseaseEpigenesis, GeneticFemaleHumansMaleMiddle AgedPainPain ThresholdPromoter Regions, GeneticSex CharacteristicsTRPA1 Cation ChannelTRPA1 Cation ChannelTRPA1 protein, humanCrohn’s diseaseIBDPressure painPromoter methylationTRPA1

Identifiers

PMID31892361
PMCPMC6938615
OpenAlexW2997143790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.